A similar phenomenon has been observed with AMG 330 (CD33×CD3) in acute myeloid leukemia, where CD33-low/negative clones were detected in ~60% of patients who initially responded but later relapsed (209). This evidence concerns the gene CD33 and acute myeloid leukemia.